These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 12211218

  • 1. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y, Nakamura K, Matsuki S, Uemura N, Muraguchi R, Nakagawa M, Nakano S, Nakatsuka K.
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 3. [Effect of 8-hydroxycarteolol in normal human eyes].
    Kato Y, Sasaki T, Tsukahara S.
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):899-903. PubMed ID: 1354411
    [Abstract] [Full Text] [Related]

  • 4. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
    Yamamoto T, Carteolol Long-acting Formulation Study Group.
    Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
    [Abstract] [Full Text] [Related]

  • 5. Effect of topical carteolol on the normal human retinal circulation.
    Grunwald JE, Delehanty J.
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1853-6. PubMed ID: 1582788
    [Abstract] [Full Text] [Related]

  • 6. Topical verapamil and episcleral venous pressure.
    Abreu MM, Kim YY, Shin DH, Netland PA.
    Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H, Niño J, Tahvanainen K, Turjanmaa V, Ropo A, Tuominen J, Kähönen M.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [Abstract] [Full Text] [Related]

  • 8. Effect of topical beta-blockers on tissue blood flow in the human optic nerve head.
    Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A.
    Curr Eye Res; 1997 Nov; 16(11):1102-10. PubMed ID: 9395769
    [Abstract] [Full Text] [Related]

  • 9. Effect of topical carteolol on tissue circulation in the optic nerve head.
    Tamaki Y, Araie M, Tomita K, Tomidokoro A.
    Jpn J Ophthalmol; 1998 Nov; 42(1):27-32. PubMed ID: 9507362
    [Abstract] [Full Text] [Related]

  • 10. Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer.
    Tamaki Y, Araie M, Tomita K, Tomidokoro A, Nagahara M.
    Surv Ophthalmol; 1997 Nov; 42 Suppl 1():S52-63. PubMed ID: 9603290
    [Abstract] [Full Text] [Related]

  • 11. Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.
    Renard P, Kovalski JL, Cochereau I, Jaulerry S, Williamson W, Elena PP, Lablache Combier M, Allaire C, Siou-Mermet R.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1221-7. PubMed ID: 16003515
    [Abstract] [Full Text] [Related]

  • 12. Effect of topical carteolol on iridial circulation in pigmented rabbit eyes.
    Tomidokoro A, Tamaki Y, Araie M, Tomita K, Muta K.
    Jpn J Ophthalmol; 1998 Dec; 42(3):180-5. PubMed ID: 9690895
    [Abstract] [Full Text] [Related]

  • 13. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM, Kaila T, Saari KM.
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.
    Ohtori R, Sato H, Fukuda S, Ueda T, Koide R, Kanda Y, Kiuchi Y, Oguchi K.
    Exp Eye Res; 1998 Apr; 66(4):487-94. PubMed ID: 9593641
    [Abstract] [Full Text] [Related]

  • 15. Effects of topical carteolol and timolol on tissue circulation in the iris and choroid.
    Tomidokoro A, Araie M, Tamaki Y, Muta K.
    Curr Eye Res; 1999 May; 18(5):381-90. PubMed ID: 10373001
    [Abstract] [Full Text] [Related]

  • 16. [Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
    Schnarr KD.
    Klin Monbl Augenheilkd; 1988 Feb; 192(2):167-72. PubMed ID: 2896266
    [Abstract] [Full Text] [Related]

  • 17. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration].
    Kawase K, Yamamoto T, Muramatsu T, Ono J, Nakajima T, Matsuhisa A, Sugiura T, Migita M, Ishikawa Y.
    Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):976-82. PubMed ID: 21141077
    [Abstract] [Full Text] [Related]

  • 18. Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma.
    Nakamoto K, Yasuda N.
    Jpn J Ophthalmol; 2010 Mar; 54(2):140-3. PubMed ID: 20401563
    [Abstract] [Full Text] [Related]

  • 19. Acute effect of topical carteolol on ocular pulsatile volume change.
    Yamazaki S, Baba H.
    Acta Ophthalmol (Copenh); 1993 Dec; 71(6):760-4. PubMed ID: 8154249
    [Abstract] [Full Text] [Related]

  • 20. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
    Demailly P, Allaire C, Trinquand C, Once-daily Carteolol Study Group.
    Br J Ophthalmol; 2001 Aug; 85(8):921-4. PubMed ID: 11466245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.